ORIGINAL ARTICLE
Year : 2017 | Volume
: 30 | Issue : 2 | Page : 405--411
Impact of vacuum-assisted closure device in the treatment of sternal wound infection
Awatef Farghaly1, Amr Allama2, Medhat Nashy2, Khaled A Sha'aban3 1 Department of General Surgery, Faculty of Medicine, Menoufia University, Al Minufya, Egypt 2 Department of Cardiothoracic Surgery, Faculty of Medicine, Menoufia University, Al Minufya, Egypt 3 Department of Cardiothoracic Surgery, Nasr City Insurance Hospital, Cairo, Egypt
Correspondence Address:
Khaled A Sha'aban Department of Cardiothoracic Surgery, Nasr City Insurance Hospital, Cairo, 11756 Egypt
Objective
The aim of this study was to evaluate the effectiveness and clinical outcome of vacuum-assisted closure (VAC) therapy in the treatment of sternal wound infection (SWI) as either a sole therapy or as a bridge for other reconstructive procedures.
Background
VAC therapy is a novel treatment employed to aid wound healing in different areas of the body and recently also in SWI after cardiac surgeries.
Patients and methods
Our study is a prospective nonrandomized study conducted on 30 patients who developed either superficial or deep SWI after cardiac surgeries. These patients were undergoing VAC therapy as a sole therapy or as a bridge for other reconstructive procedures.
Results
The mean duration of VAC therapy was 12.7 (range: 4–27) days. The mean length of hospital stay was 27 (range 14–65) days.Twenty-nine (95%) patients were treated successfully. Hospital mortality occurred in one (3.33%) patient because of septic shock and multiple organ failure. At the end of VAC therapy, the mean reduction in wound size was 34.3%. The mean granulation tissue formation was 64%. VAC therapy was used as definitive therapy in 63.33% and as a bridge to conventional methods in 33.3% of cases.
Conclusion
VAC is a safe, reliable, and relatively new option for the treatment of devastating SWI after cardiac surgery. It is important to find a strategy that may be used as a 'standard VAC therapy approach' if identified in the future. Finally, we conclude that VAC therapy should be considered as a first-line treatment for most SWI.
How to cite this article:
Farghaly A, Allama A, Nashy M, Sha'aban KA. Impact of vacuum-assisted closure device in the treatment of sternal wound infection.Menoufia Med J 2017;30:405-411
|
How to cite this URL:
Farghaly A, Allama A, Nashy M, Sha'aban KA. Impact of vacuum-assisted closure device in the treatment of sternal wound infection. Menoufia Med J [serial online] 2017 [cited 2024 Mar 29 ];30:405-411
Available from: http://www.mmj.eg.net/article.asp?issn=1110-2098;year=2017;volume=30;issue=2;spage=405;epage=411;aulast=Farghaly;type=0 |
|
|